Literature DB >> 2607509

Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis.

G A McCain1, K S Tilbe.   

Abstract

Twenty patients with fibromyalgia syndrome and 20 patients with rheumatoid arthritis (RA) were assessed as outpatients over a 3 day period with respect to peak and trough levels of plasma cortisol, growth hormone, prolactin, ACTH and thyroid stimulating hormone. Patients with fibromyalgia syndrome had loss of diurnal variation in plasma cortisol (trough levels 347.3 +/- 254.7 vs 232.8 +/- 70.0 nmol/l, p less than 0.001) compared with RA patients. Thirty-five percent (7/20) of patients with fibromyalgia syndrome and only 5 percent (1/20) of those with RA exhibited abnormal dexamethasone suppression tests (p less than 0.001). No differences were noted in the diurnal variation of other hormones tested. Beck Depression Inventory scores were similar in both groups and no patient exhibited clinical evidence of depression. These data suggest alteration in the pituitary hypothalamic axis with respect to cortisol secretion in fibromyalgia syndrome, perhaps as a consequence of chronic pain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2607509

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  41 in total

1.  Fibromyalgia syndrome is associated with hypocortisolism.

Authors:  Roberto Riva; Paul Jarle Mork; Rolf Harald Westgaard; Magne Rø; Ulf Lundberg
Journal:  Int J Behav Med       Date:  2010-09

2.  Day-to-day dynamics of experience--cortisol associations in a population-based sample of older adults.

Authors:  Emma K Adam; Louise C Hawkley; Brigitte M Kudielka; John T Cacioppo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

3.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 5.  Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.

Authors:  L A Bradley; N L McKendree-Smith; G S Alarcón
Journal:  Curr Rev Pain       Date:  2000

Review 6.  Chronic pain assessment from bench to bedside: lessons along the translation continuum.

Authors:  Bryan Jensen
Journal:  Transl Behav Med       Date:  2016-12       Impact factor: 3.046

7.  Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.

Authors:  Samuel A McLean; David A Williams; Phyllis K Stein; Richard E Harris; Angela K Lyden; Gail Whalen; Karen M Park; Israel Liberzon; Ananda Sen; Richard H Gracely; James N Baraniuk; Daniel J Clauw
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

Review 8.  Neuroimmune mechanisms in health and disease: 2. Disease.

Authors:  H Anisman; M G Baines; I Berczi; C N Bernstein; M G Blennerhassett; R M Gorczynski; A H Greenberg; F T Kisil; R D Mathison; E Nagy; D M Nance; M H Perdue; D K Pomerantz; E R Sabbadini; A Stanisz; R J Warrington
Journal:  CMAJ       Date:  1996-10-15       Impact factor: 8.262

9.  Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome.

Authors:  Charles W Denko; Charles J Malemud
Journal:  Rheumatol Int       Date:  2004-07-24       Impact factor: 2.631

Review 10.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.